Eli Lilly (LLY) Gross Profit (2009 - 2026)

Eli Lilly (LLY) has reported Gross Profit for 18 consecutive years, with $16.2 billion the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $16.2 billion, up 54.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.8 billion (up 49.48% YoY), and the FY2025 annual result was $54.1 billion, up 47.79% from the prior year.
• Gross Profit was $16.2 billion for Q1 2026 at Eli Lilly, up from $15.9 billion in the prior quarter.
• Over five years, Gross Profit peaked at $16.2 billion in Q1 2026 and troughed at $5.1 billion in Q2 2022.
• Average Gross Profit over 5 years is $9.2 billion, with a median of $7.6 billion recorded in 2023.
• Year-over-year, Gross Profit fell 7.05% in 2023 and surged 57.45% in 2025.
• Over 5 years, Gross Profit stood at $5.8 billion in 2022, then soared by 31.49% to $7.6 billion in 2023, then surged by 47.11% to $11.1 billion in 2024, then surged by 43.04% to $15.9 billion in 2025, then climbed by 1.9% to $16.2 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $16.2 billion in Q1 2026, $15.9 billion in Q4 2025, and $14.6 billion in Q3 2025.